SHPHY 财务： Sihuan Pharmaceutical Holdings Group Ltd AI 分析

主页

股票

SHPHY

财务数据

SHPHY 财务

Sihuan Pharmaceutical Holdings Group Ltd

0%

$0

收盘价：Mar 27, 16:00:00 GMT-4

0%

$0

盘后：Mar 27, 20:00:00 GMT-4

概述预测收益股息财务数据

收入

资产负债表

现金流量

年度

季度性

SHPHY 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
营收	2,097	1,901	1,860	2,181	3,038	2,464
营收同比增长 (YoY)	20%	2%	-15%	-28%	23%	-14%
营收成本	707	659	564	693	607	549
毛利润	1,390	1,241	1,295	1,487	2,430	1,914
销售、一般及管理费用	1,165	1,175	911	1,023	1,128	858
研发	431	473	577	936	868	729
营业费用	1,544	1,631	1,436	2,023	1,754	1,428
其他非经营性收入 (费用)	--	--	--	--	--	--
税前利润	-252	-428	-161	-2,122	496	765
所得税费用	85	43	96	196	253	219
净利润	-80	-216	-54	-1,914	416	473
净利润增长	115.99%	300%	-97%	-560%	-12%	-117%
稀释后流通股数	9,204.01	9,265.98	9,297.07	9,329.99	9,483.38	9,465.68
股份同比变动 (YoY)	-1%	0%	0%	-2%	0%	0%
每股收益 (摊薄)	0	-0.02	0	-0.2	0.04	0.05
每股收益增长率	112%	303%	-97%	-565%	-16%	-119%
自由现金流	-71	57	-95	-547	-60	-353
每股自由现金流	--	--	--	--	--	--
毛利率	66.28%	65.28%	69.62%	68.17%	79.98%	77.67%
营业利润率	-7.34%	-20.46%	-7.52%	-24.57%	22.25%	19.68%
净利率	-3.81%	-11.36%	-2.9%	-87.75%	13.69%	19.19%
自由现金流利润率	-3.38%	2.99%	-5.1%	-25.08%	-1.97%	-14.32%
EBITDA	78	-143	76	-175	977	755
EBITDA 利润率	3.71%	-7.52%	4.08%	-8.02%	32.15%	30.64%
EBITDA 中的折旧与摊销	232	246	216	361	301	270
EBIT	-154	-389	-140	-536	676	485
EBIT 利润率	-7.34%	-20.46%	-7.52%	-24.57%	22.25%	19.68%
有效税率	-33.73%	-10.04%	-59.62%	-9.23%	51%	28.62%

Follow-Up Questions

Sihuan Pharmaceutical Holdings Group Ltd 的关键财务报表是什么？



根据最新的财务报表（Form-10K），Sihuan Pharmaceutical Holdings Group Ltd 的总资产为 $10,531，净损失为 $-216

SHPHY 的关键财务比率是什么？



Sihuan Pharmaceutical Holdings Group Ltd 的流动比率是 1.7，净利 margin 为 -11.36，每股销售为 $0.2。

Sihuan Pharmaceutical Holdings Group Ltd 的收入按细分市场或地理位置如何划分？



Sihuan Pharmaceutical Holdings Group Ltd 最大收入来源是 Generic Medicine，在最近的收益报告中收入为 1,191,874,310。就地区而言， China 是 Sihuan Pharmaceutical Holdings Group Ltd 的主要市场，收入为 2,047,607,773。

Sihuan Pharmaceutical Holdings Group Ltd 是否盈利？



不，根据最新的财务报表，Sihuan Pharmaceutical Holdings Group Ltd 的净损失为 $-216

Sihuan Pharmaceutical Holdings Group Ltd 有负债吗？



是的，Sihuan Pharmaceutical Holdings Group Ltd 的负债为 6,159

Sihuan Pharmaceutical Holdings Group Ltd 的流通股有多少？



Sihuan Pharmaceutical Holdings Group Ltd 的总流通股为 9,244.06

关键数据

前收盘价

开盘价

当日区间

52周范围

交易量

平均成交量

股息收益率

每股收益（TTM）

市值

什么是 SIHUAN PHARMACEUTICAL HOLD GP L？

Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 2,767 full-time employees. The company went IPO on 2010-10-28. The firm operates its business through three segments. The Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetic comprehensive solutions. The Innovative Medicine and Other Medicine segment is engaged in the research and development and commercialization of innovative medicine in the disease fields of diabetes, breast cancer, digestion disorders, oncology and non-alcoholic steatohepatitis and others. The Generic Medicine segment is engaged in the production and sale of generic medicine including Kelin’ao and other products. The firm conducts its business in the domestic and overseas markets.

功能特性

资源